Cargando…

The efficacy of parecoxib in improving pain after total knee or total hip arthroplasty: Systematic review and meta-analysis

The cyclooxygenase-2 (COX-2) selective inhibitor parecoxib is widely used in the treatment of pain and inflammation. Parecoxib has been adopted for use for postoperative analgesia following a range of surgical procedures (orthopedic, general, gynecological, and dental surgery). Total knee or total h...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Chuan, Xie, Hai-Yan, Ge, Wu-Kun, Yu, Min, Lin, Shuai-nan, Liu, Cheng-Jiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509050/
https://www.ncbi.nlm.nih.gov/pubmed/36197263
http://dx.doi.org/10.1097/MD.0000000000030748
_version_ 1784797151298060288
author Hong, Chuan
Xie, Hai-Yan
Ge, Wu-Kun
Yu, Min
Lin, Shuai-nan
Liu, Cheng-Jiang
author_facet Hong, Chuan
Xie, Hai-Yan
Ge, Wu-Kun
Yu, Min
Lin, Shuai-nan
Liu, Cheng-Jiang
author_sort Hong, Chuan
collection PubMed
description The cyclooxygenase-2 (COX-2) selective inhibitor parecoxib is widely used in the treatment of pain and inflammation. Parecoxib has been adopted for use for postoperative analgesia following a range of surgical procedures (orthopedic, general, gynecological, and dental surgery). Total knee or total hip arthroplasty (THA) surgery is mostly done in older patients, so postoperative analgesics need to be used more carefully, and the safety and efficacy of parecoxib in this type of surgery need to be further verified. The aim of this study was to investigate the effects of parecoxib on patient safety, cumulative morphine consumption and was at 24 and 48 hours in the analgesic treatment of total knee or THA for meta-analysis and systematic review, with few studies in this area so far. METHODS: We searched the Online Database Cochrane Library, PubMed, Web of Science, EMBASE, and CBM (SinoMed), CNKI, VIP, WANFANG up to January 2021. According to the value of I(2), the random-effect model or fixed-effect model was supposed to combine data from studies, respectively. Publication bias was assessed through funneling plot and Beggs test. Review Manager 5.3 and Stata 16.0 software were applied to perform the statistical analyses. RESULTS: Eleven RCTs which involved 1690 participants were included in this study. The meta-analysis indicated parecoxib sodium could not significantly reduce the incidence of adverse events after total knee or THA compared with placebo. There was no statistical significance in incidence of nausea and vomiting. 24 hours resting VAS score was statistically significant between the group. The 48-hour resting VAS scores did not indicate a significant difference between the groups. CONCLUSION: Parecoxib can reduce the incidence of adverse events after total knee or total hip surgery to some extent but cannot reduce the incidence of nausea and vomiting. Twenty-four hour postoperative analgesia is better than placebo, but 48 hours after operation analgesia is the same as placebo.
format Online
Article
Text
id pubmed-9509050
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-95090502022-09-26 The efficacy of parecoxib in improving pain after total knee or total hip arthroplasty: Systematic review and meta-analysis Hong, Chuan Xie, Hai-Yan Ge, Wu-Kun Yu, Min Lin, Shuai-nan Liu, Cheng-Jiang Medicine (Baltimore) Research Article The cyclooxygenase-2 (COX-2) selective inhibitor parecoxib is widely used in the treatment of pain and inflammation. Parecoxib has been adopted for use for postoperative analgesia following a range of surgical procedures (orthopedic, general, gynecological, and dental surgery). Total knee or total hip arthroplasty (THA) surgery is mostly done in older patients, so postoperative analgesics need to be used more carefully, and the safety and efficacy of parecoxib in this type of surgery need to be further verified. The aim of this study was to investigate the effects of parecoxib on patient safety, cumulative morphine consumption and was at 24 and 48 hours in the analgesic treatment of total knee or THA for meta-analysis and systematic review, with few studies in this area so far. METHODS: We searched the Online Database Cochrane Library, PubMed, Web of Science, EMBASE, and CBM (SinoMed), CNKI, VIP, WANFANG up to January 2021. According to the value of I(2), the random-effect model or fixed-effect model was supposed to combine data from studies, respectively. Publication bias was assessed through funneling plot and Beggs test. Review Manager 5.3 and Stata 16.0 software were applied to perform the statistical analyses. RESULTS: Eleven RCTs which involved 1690 participants were included in this study. The meta-analysis indicated parecoxib sodium could not significantly reduce the incidence of adverse events after total knee or THA compared with placebo. There was no statistical significance in incidence of nausea and vomiting. 24 hours resting VAS score was statistically significant between the group. The 48-hour resting VAS scores did not indicate a significant difference between the groups. CONCLUSION: Parecoxib can reduce the incidence of adverse events after total knee or total hip surgery to some extent but cannot reduce the incidence of nausea and vomiting. Twenty-four hour postoperative analgesia is better than placebo, but 48 hours after operation analgesia is the same as placebo. Lippincott Williams & Wilkins 2022-09-23 /pmc/articles/PMC9509050/ /pubmed/36197263 http://dx.doi.org/10.1097/MD.0000000000030748 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Hong, Chuan
Xie, Hai-Yan
Ge, Wu-Kun
Yu, Min
Lin, Shuai-nan
Liu, Cheng-Jiang
The efficacy of parecoxib in improving pain after total knee or total hip arthroplasty: Systematic review and meta-analysis
title The efficacy of parecoxib in improving pain after total knee or total hip arthroplasty: Systematic review and meta-analysis
title_full The efficacy of parecoxib in improving pain after total knee or total hip arthroplasty: Systematic review and meta-analysis
title_fullStr The efficacy of parecoxib in improving pain after total knee or total hip arthroplasty: Systematic review and meta-analysis
title_full_unstemmed The efficacy of parecoxib in improving pain after total knee or total hip arthroplasty: Systematic review and meta-analysis
title_short The efficacy of parecoxib in improving pain after total knee or total hip arthroplasty: Systematic review and meta-analysis
title_sort efficacy of parecoxib in improving pain after total knee or total hip arthroplasty: systematic review and meta-analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509050/
https://www.ncbi.nlm.nih.gov/pubmed/36197263
http://dx.doi.org/10.1097/MD.0000000000030748
work_keys_str_mv AT hongchuan theefficacyofparecoxibinimprovingpainaftertotalkneeortotalhiparthroplastysystematicreviewandmetaanalysis
AT xiehaiyan theefficacyofparecoxibinimprovingpainaftertotalkneeortotalhiparthroplastysystematicreviewandmetaanalysis
AT gewukun theefficacyofparecoxibinimprovingpainaftertotalkneeortotalhiparthroplastysystematicreviewandmetaanalysis
AT yumin theefficacyofparecoxibinimprovingpainaftertotalkneeortotalhiparthroplastysystematicreviewandmetaanalysis
AT linshuainan theefficacyofparecoxibinimprovingpainaftertotalkneeortotalhiparthroplastysystematicreviewandmetaanalysis
AT liuchengjiang theefficacyofparecoxibinimprovingpainaftertotalkneeortotalhiparthroplastysystematicreviewandmetaanalysis
AT hongchuan efficacyofparecoxibinimprovingpainaftertotalkneeortotalhiparthroplastysystematicreviewandmetaanalysis
AT xiehaiyan efficacyofparecoxibinimprovingpainaftertotalkneeortotalhiparthroplastysystematicreviewandmetaanalysis
AT gewukun efficacyofparecoxibinimprovingpainaftertotalkneeortotalhiparthroplastysystematicreviewandmetaanalysis
AT yumin efficacyofparecoxibinimprovingpainaftertotalkneeortotalhiparthroplastysystematicreviewandmetaanalysis
AT linshuainan efficacyofparecoxibinimprovingpainaftertotalkneeortotalhiparthroplastysystematicreviewandmetaanalysis
AT liuchengjiang efficacyofparecoxibinimprovingpainaftertotalkneeortotalhiparthroplastysystematicreviewandmetaanalysis